Table 1.
Organ/Systems/Condition | Effect | Reference |
---|---|---|
Liver | Increases the expression of hepatic lipogenic genes and PPARγ | [14] |
Cardiovascular system | Increases angiogenesis, blood flow, capillary density, and protects endothelial cells | [23] |
Improves cardiac function and coronary flow | [77] | |
Diabetes mellitus | Low adropin level increases the risk of chronic complications of diabetes | [63,64,65] |
Stimulates insulin signal pathways by promoting Akt phosphorylation | [20] | |
Fat | Suppresses lipid accumulation | [78,79] |
Inflammation | Inhibits TNF-α | [80] |